AuroMedics Recalls Levofloxacin Injection Bags Due to Sterility Concerns
AuroMedics Pharma LLC is recalling specific lots of Levofloxacin in 5% Dextrose Injection due to a lack of assurance of sterility and reports of leaking bags with mold.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility with confirmed reports of mold and leaking bags, which poses a significant risk of serious injury or infection.
Plain-English summary
AuroMedics Pharma LLC is recalling 308,472 bags of Levofloxacin in 5% Dextrose Injection, 500 mg (5 mg/mL) in 100 mL, for intravenous infusion. The recall is being conducted because of a lack of assurance of sterility. The company received a confirmed customer report of leaking bags and mold found between the outer bag and the overwrap.
The affected product is manufactured by Aurobindo Pharma Limited in India for AuroMedics Pharma, LLC. The recall covers specific lot numbers with expiration dates ranging from June 2018 to August 2019. The product was distributed nationwide in the United States.
Healthcare providers and patients should stop using the affected lots immediately. Patients who have received the medication should contact their healthcare provider for further instructions. The recall is classified as FDA Class II, indicating a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- LEVOFLOXACIN (LEVOFLOXACIN IN 5% DEXTROSE)
- Brand
- LEVOFLOXACIN
- Manufacturer
- AuroMedics Pharma LLC
- Category
- Drug — Antibiotic Injection
- Affected units
- 308,472
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot/Batch #'s: CLF160008
- CLF160009
- CLF160010
- CLF160011
- exp June 2018
- CLF160015
- CLF160016
- CLF160017
- exp August 2018
- CLF170001 exp December 2018
- CLF170023
- CLF170024
- exp May 2019
- CLF170039
- CLF170040
- CLF170041
- CLF170042
- CLF170043
- CLF170044
- CLF170045
UPCs (1)
- 0355150244478
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by AuroMedics Pharma LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same brand · LEVOFLOXACIN
- HighLevofloxacin 500 mg Tablets Recalled Due to Manufacturing Temperature Abuse
FDA (Drugs) · 2022-06-15
- SevereCardinal Health Recalls Levofloxacin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateBaxter Recalls Levofloxacin Injection Bags Due to High Potency
FDA (Drugs) · 2018-10-03
- ModerateBaxter Recalls Levofloxacin Injection Due to High Potency Levels
FDA (Drugs) · 2018-08-15
- ModerateBaxter Recalls Levofloxacin Injection Due to High Concentration Levels
FDA (Drugs) · 2018-08-15
Same manufacturer · AuroMedics Pharma LLC
See all →- HighFondaparinux Sodium Injection Recalled Nationwide for Subpotent Formulation
FDA (Drugs) · 2022-11-02
- HighAcyclovir Sodium Injectable Recalled for Particulate Matter
FDA (Drugs) · 2022-10-26
- LowTranexamic Acid Injection Recalled for Metal Particulate Matter
FDA (Drugs) · 2022-10-12
- SeverePolymyxin B for Injection Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2022-02-16
- SevereAuroMedics Recalls Acetaminophen Injection Due to Discoloration and pH Failures
FDA (Drugs) · 2021-02-10
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29